ylliX - Online Advertising Network
Press Release

MGC Pharmaceuticals partners begin long-Covid study using ArtemiC Support

MGC Pharmaceuticals partners begin long-Covid study using ArtemiC Support

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said a clinical study is underway to assess the potential of its supplement ArtemiC Support to treat people with long-Covid. Partners Swiss PharmaCan (TSX-V:MJN) and Glow LifeTech are carrying out the research which should be complete in February.

...read full article on Proactive Investors

ylliX - Online Advertising Network